Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 1.92 CAD -2.54% Market Closed
Market Cap: 53m CAD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+10%
5Y
-
10Y
+325%
Liabilities
+
3Y
+20%
5Y
-
10Y
+101%
Equity
+
3Y
+8%
5Y
-
10Y
+435%

Balance Sheet Decomposition
Covalon Technologies Ltd

35.2m
Assets
5.6m
Liabilities
35.2m
Assets
5.6m
Liabilities
Current Assets 31.7m
Cash & Short-Term Investments 18.1m
Receivables 4.7m
Other Current Assets 8.9m
Non-Current Assets 3.5m
PP&E 2.2m
Intangibles 1.3m
Other Non-Current Assets 11.7k
Current Liabilities 4.8m
Accounts Payable 4.2m
Other Current Liabilities 629.7k
Non-Current Liabilities 732.2k
Long-Term Debt 732.2k

Balance Sheet
Covalon Technologies Ltd

Rotate your device to view
Balance Sheet
Currency: CAD
Sep-2003 Sep-2004 Sep-2005 Sep-2006 Sep-2007 Sep-2008 Sep-2009 Sep-2010 Sep-2011 Sep-2012 Sep-2013 Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2024
Assets
Cash & Cash Equivalents
0
1
1
5
7
4
6
6
5
1
1
4
1
1
4
5
10
4
23
14
0
Cash
0
1
1
5
7
4
0
1
1
0
0
0
0
0
0
0
0
4
0
0
0
Cash Equivalents
0
0
0
0
0
0
6
5
4
1
0
4
1
1
4
5
10
0
23
14
0
Short-Term Investments
0
0
0
0
9
9
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
1
0
0
1
1
1
2
1
3
5
4
3
6
5
4
Accounts Receivables
0
0
0
0
0
0
1
0
0
1
1
1
2
1
3
5
4
3
6
5
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
6
9
7
5
5
8
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
3
3
1
Total Current Assets
1
1
1
6
17
13
8
7
6
3
3
5
5
4
10
17
22
15
37
27
29
PP&E Net
0
0
0
0
1
1
1
1
1
1
1
0
0
0
1
1
2
5
2
2
1
PP&E Gross
0
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
2
5
2
2
0
Accumulated Depreciation
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
2
2
3
2
0
Intangible Assets
0
0
0
0
0
1
1
1
1
2
1
2
2
2
2
1
2
2
1
1
1
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
2
3
2
2
3
4
2
2
4
1
0
0
0
0
0
1
1
1
0
0
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
0
0
0
Total Assets
2
N/A
3
+37%
5
+52%
9
+95%
20
+130%
17
-15%
13
-26%
10
-20%
9
-10%
6
-36%
6
-5%
8
+40%
8
-4%
6
-15%
12
+84%
20
+65%
40
+101%
35
-12%
41
+17%
30
-25%
32
+5%
Liabilities
Accounts Payable
1
0
1
1
1
1
1
1
1
2
1
1
1
2
2
5
6
4
4
3
0
Short-Term Debt
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
2
8
8
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
1
1
1
Other Current Liabilities
0
0
0
0
2
0
1
1
1
1
1
1
0
0
0
0
4
11
0
1
0
Total Current Liabilities
1
2
1
1
3
1
1
2
2
2
2
1
2
2
3
6
18
23
5
5
4
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
3
2
2
0
Other Liabilities
0
0
0
0
0
1
1
1
1
0
0
0
1
1
0
0
7
0
0
0
0
Total Liabilities
1
N/A
2
+180%
1
-63%
1
-25%
3
+400%
2
-14%
2
-15%
3
+42%
2
-16%
3
+18%
3
0%
2
-11%
3
+17%
3
-6%
3
+11%
7
+120%
25
+275%
26
+4%
7
-72%
6
-15%
4
-30%
Equity
Common Stock
6
6
10
16
29
29
29
29
32
32
32
32
32
35
38
39
45
45
45
44
52
Retained Earnings
4
5
6
9
11
14
19
24
27
30
32
30
31
34
32
30
41
48
24
34
36
Additional Paid In Capital
0
0
0
1
0
0
0
2
2
2
2
3
3
3
3
4
11
12
12
11
8
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
3
3
Total Equity
1
N/A
1
-30%
4
+268%
8
+118%
18
+113%
15
-15%
11
-27%
8
-31%
7
-7%
3
-54%
3
-9%
6
+87%
5
-13%
4
-20%
9
+136%
13
+46%
15
+14%
9
-39%
33
+266%
24
-27%
28
+16%
Total Liabilities & Equity
2
N/A
3
+37%
5
+52%
9
+95%
20
+130%
17
-15%
13
-26%
10
-20%
9
-10%
6
-36%
6
-5%
8
+40%
8
-4%
6
-15%
12
+84%
20
+65%
40
+101%
35
-12%
41
+17%
30
-25%
32
+5%
Shares Outstanding
Common Shares Outstanding
1
1
4
6
7
7
7
7
8
8
9
9
9
19
21
22
26
26
26
25
27

See Also

Summary
COV intrinsic value, competitors valuation, and company profile.
DCF Valuation
COV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COV stock valuation using valuation multiples.
Wall Street Estimates
COV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 301,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.